Skip to content

Antares Pharma, Inc.: filings

Every Antares Pharma, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 44 filings, each linked to its SEC index.

Filing record ends 2022-05-10

The latest filing in this captured record is a 10-Q filed 2022-05-10. No later filing is in the SEC companyfacts record captured on 2026-09-22. Antares Pharma, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2022-05-10fiscal Q1 2022521050001016169-22-000044
10-K2022-03-03fiscal FY 2021571450001016169-22-000028
10-Q2021-11-04fiscal Q3 2021511400001016169-21-000045
10-Q2021-08-05fiscal Q2 2021471260001564590-21-041726
10-Q2021-05-06fiscal Q1 202147950001564590-21-025088
10-K2021-03-02fiscal FY 2020571670001564590-21-010298
10-Q2020-11-05fiscal Q3 2020451180001564590-20-051289
10-Q2020-08-06fiscal Q2 2020431100001564590-20-037823
10-Q2020-05-05fiscal Q1 202042850001564590-20-021313
10-K2020-03-03fiscal FY 2019511600001564590-20-008465
10-Q2019-11-05fiscal Q3 2019471160001564590-19-040388
10-Q2019-08-06fiscal Q2 2019451100001564590-19-029313
10-Q2019-05-02fiscal Q1 201943840001564590-19-015362
10-K2019-03-12fiscal FY 2018491470001564590-19-007398
10-Q2018-11-06fiscal Q3 2018411020001564590-18-027476
10-Q2018-08-07fiscal Q2 2018411010001564590-18-019977
10-Q2018-05-08fiscal Q1 201836730001564590-18-011774
10-K2018-03-13fiscal FY 2017461430001564590-18-005459
10-Q2017-11-07fiscal Q3 201737940001564590-17-022312
10-Q2017-08-08fiscal Q2 201736920001564590-17-016561
10-Q2017-05-09fiscal Q1 201735690001564590-17-009910
10-K2017-03-14fiscal FY 2016441420001564590-17-004282
10-Q2016-11-09fiscal Q3 201634870001564590-16-028605
10-Q2016-08-09fiscal Q2 201634870001564590-16-023611
10-Q2016-05-09fiscal Q1 201633660001564590-16-018621
10-K2016-03-08fiscal FY 2015431380001564590-16-014226
10-Q2015-11-05fiscal Q3 201534870001564590-15-009728
10-Q2015-08-10fiscal Q2 201535910001193125-15-285052
10-Q2015-05-11fiscal Q1 201534700001193125-15-182167
10-K2015-03-12fiscal FY 2014441390001193125-15-088373
10-Q2014-11-06fiscal Q3 201434900001193125-14-401115
10-Q2014-08-07fiscal Q2 201434900001193125-14-300641
10-Q2014-05-09fiscal Q1 201434700001193125-14-192696
10-K2014-03-13fiscal FY 2013451370001193125-14-097968
10-Q2013-11-06fiscal Q3 201336940001193125-13-430417
10-Q2013-08-07fiscal Q2 201336940001193125-13-324350
10-Q2013-05-08fiscal Q1 201338780001193125-13-207601
10-K2013-03-13fiscal FY 2012411290001193125-13-105398
10-Q2012-11-07fiscal Q3 2012391050001193125-12-457656
10-Q2012-08-08fiscal Q2 2012391040001193125-12-344163
10-Q2012-05-08fiscal Q1 201237760001140361-12-023637
10-K2012-03-12fiscal FY 2011391020001016169-12-000005
10-Q2011-11-08fiscal Q3 201137940001016169-11-000027
10-Q2011-08-08fiscal Q2 201137940001016169-11-000023

Inspect the source

Entity
Antares Pharma, Inc. / CIK 0001016169
Captured
SEC response SHA-256
540b8a117c7898b4d835a42d9aec42c261c74ea0da49d4755fcc6f2d9b68be71

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001016169.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))